Suscribirse

Rhabdomyolysis and coeliac disease: A causal or casual association? A case report and review of literature - 21/02/18

Doi : 10.1016/j.clinre.2017.05.002 
Claudia Mandato a, , Alessandro Rossi b, Mariano Caldore a, Marta Lamba a, Michele Rocco c, Renata Auricchio b, Pietro Vajro d, Paolo Siani a
a Department of Pediatrics, AORN Santobono-Pausilipon, via M. Fiore, 80129 Naples, Italy 
b Department of Traslational Medicine, University of Naples Federico II, 80131 Naples, Italy 
c Department of Services, Pathology, AORN Santobono-Pausilipon, via M. Fiore, 80129 Naples, Italy 
d Department of Medicine, Surgery, and Dentistry “Scuola Medica Salernitana”, Pediatrics Section, University of Salerno, 84081, Baronissi (Salerno), Italy 

Corresponding author.

Summary

Background

Rhabdomyolysis is a rare, potentially life-threatening condition, caused by multiple disorders. The association with Coeliac Disease (CD) has been rarely reported and in these cases muscular damage was imputed to hypokalemia. Herein we describe a new case of severe rhabdomyolysis in a child subsequently diagnosed as affected by CD, and review previous reports.

Case presentation

A 3-year-old boy was referred for diarrhea, brown urine, muscular pain/weakness, and no history of muscular trauma. At entry, laboratory tests showed elevated levels of creatine kinase (CK) (x100 unv) and aspartate aminotransferase (AST) (x10 unv), alanine aminotrasferase (ALT) (x5 unv); electrolytes were within the reference range. Twenty-four hours after admission serum CK peaked 115,000 U/L and transaminases increased up to 30 times unv. Hyperhydration treatment was started with renal function monitoring. Urine output decreased little, while serum creatinine and urea nitrogen stayed within the reference range. Serum potassium levels went down to 2.8 mEq/L at day 3, in spite of supplementation. The patient completely recovered at day 16. Main metabolic causes of rhabdomyolysis were ruled out by appropriate tests. Because of rarely reported cases of CD/rhabdomyolysis, anti-tissue transglutaminase (tTG) antibodies were measured and found positive (IgA 34 U/mL, unv <9). HLA typing was DQA1 05:02, DQB1 03:02. As jejunal biopsy showed patchy villous atrophy, gluten free diet (GFD) was prescribed. One year after starting GFD, histology was normal.

Review of literature

Literature (search engines: PUB MED and GOOGLE SCHOLAR) from 1980 to 2016 retrieved 8 cases (age range: 12 to 75 years old) previously described.

Conclusion

The present case suggests to check for CD in children with severe rhabdomyolysis. Because severe rhabdomyolysis itself may elevate the serum potassium levels, hypokalemia might go unrecognized as the cause of muscular damage.

El texto completo de este artículo está disponible en PDF.

Keywords : Rhabdomyolysis, Coeliac disease, Hypokalemia


Esquema


© 2017  Elsevier Masson SAS. Reservados todos los derechos.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 42 - N° 1

P. e7-e13 - février 2018 Regresar al número
Artículo precedente Artículo precedente
  • A case of esophageal tuberculosis with unusual endoscopic feature
  • Yi-Xuan Li, Wei-Dong Nian, Hua-Hong Wang
| Artículo siguiente Artículo siguiente
  • Diagnostic yield of capsule endoscopy in premenopausal and menopausal women with obscure gastrointestinal bleeding
  • Guillaume Perrod, Camille Lorenceau-Savale, Gabriel Rahmi, Christophe Cellier

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.

¿Ya suscrito a @@106933@@ revista ?

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2024 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.